Growing evidence supports the existence of an intermediate metastatic disease state.
Christopher B. Anderson MD, MPH
Advertisement
Anderson is an assistant professor of urology at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.
Articles by Christopher B. Anderson MD, MPH
Advertisement
Latest Updated Articles
Management of hormone-naïve oligometastatic prostate cancerPublished: November 23rd 2021 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
Michael Cookson, MD, discusses new strategies for treatment intensification in prostate cancer
5
